Targeting Tobacco Cessation During Treatment for Cannabis Use Disorders

Cannabis Dependence Clinical Trial

Official title:

Targeting Tobacco Cessation During Treatment for Cannabis Use Disorders

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01834794
• Other study ID #: 32243 D14201
• Secondary ID: 1R01DA032243-01
• Status: Completed
• Phase: N/A
• Start date: March 2013
• Est. completion date: January 2015

Study information

• Verified date: January 2019
• Source: Dartmouth-Hitchcock Medical Center
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

This project aims to develop and test an intervention for the simultaneous treatment of cannabis use disorders and tobacco smoking. This is important because over 50% of adults seeking treatment to help stop cannabis use also smoke tobacco regularly, which decreases their chance for a successful treatment outcome and increases adverse acute and long-term psychosocial and health consequences. The proposed treatment will integrate existing computer-based behavioral interventions for cannabis and tobacco and use nicotine replacement medications to improve outcomes in this difficult to treat clinical population.

Description:

Approximately 50% of persons seeking treatment for cannabis-use disorders (CUDs) regularly smoke tobacco. Combining tobacco with cannabis has become a common method of smoking cannabis. Similarities of use, and using together, can make quitting difficult. Stopping tobacco simultaneously with cannabis may be beneficial. Little scientific information currently addresses how to best target tobacco smoking during treatment for CUDs. Our long-term goal is to develop an effective protocol for intervening in tobacco smoking without changing cannabis outcomes. A two-phase, Stage 1 therapy development project will accomplish the following: First, a treatment protocol and manual will be developed that integrates a tailored intervention for tobacco smoking with an intervention for CUD (Aim 1). Utilization of web-based counseling programs will standardize delivery of the intervention and foster eventual dissemination. A pilot study will provide an initial test of acceptability and feasibility. Second, a Stage 1, proof-of-concept study will compare this intervention to one that targets CUD only (Aim 2). The hypotheses assert that the intervention (1) will be accepted by the majority of eligible participants (2) will result in more tobacco quit attempts and rates than the CUD-only treatment; and (3) will not adversely affect cannabis outcomes. Last, the project will evaluate the potential of specific moderators of outcomes to predict outcomes and inform subsequent treatment development efforts (Aim 3). If the hypotheses were confirmed, dissemination of this protocol would reduce adverse psychosocial and health consequences of tobacco or cannabis dependence. Findings will inform future development of prevention and intervention strategies.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 33
• Est. completion date: January 2015
• Est. primary completion date: January 2015
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 65 Years

Eligibility

Inclusion Criteria:

• 18-65 years old

• current DSM-IV diagnosis of cannabis abuse or dependence

• report use of cannabis on at least 45 of previous 90 days

• report regular use of tobacco cigarettes or report that their primary administration of cannabis is via blunts or spliffs

• some indication of interest in quitting tobacco in the next 6 months (rating of 2 or more on a 5-point interest scale

Exclusion Criteria:

• current dependence on alcohol or any drug other than tobacco and cannabis

• active or recent suicidal ideation

• use of non-tobacco nicotine

• current participation in treatment for substance abuse

• severe psychological distress (e.g., active suicidal plans, psychosis, debilitating panic disorder).

• a condition that requires seeing a physician before using NRT (e.g., pregnancy or recent heart attack

• legal status that would interfere with participation

• living with someone enrolled in the project

• not living within 30 miles of the research site (unless an exception is authorized by the PI)

• not being fluent in english

Related Conditions & MeSH terms

• Cannabis Dependence
• Marijuana Abuse

Intervention

Behavioral:
• MET/CBT/CM plus NRT
Behavioral Treatment for Cannabis plus Behavioral Treatment for Tobacco: both primarily delivered by computer. Additional NRT.

Locations

Country	Name	City	State
United States	Geisel School of Medicine at Dartmouth; State Building Site	Concord	New Hampshire
United States	Geisel School of Medicine at Dartmouth; Rivermill Complex Site	Lebanon	New Hampshire

Sponsors (2)

Lead Sponsor	Collaborator
Dartmouth-Hitchcock Medical Center	National Institute on Drug Abuse (NIDA)

Country where clinical trial is conducted

United States, 

References & Publications (1)

Lee DC, Budney AJ, Brunette MF, Hughes JR, Etter JF, Stanger C. Treatment models for targeting tobacco use during treatment for cannabis use disorder: case series. Addict Behav. 2014 Aug;39(8):1224-30. doi: 10.1016/j.addbeh.2014.04.010. Epub 2014 Apr 13. — View Citation

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Tobacco Quit Attempts	Sum of 24 hour quit attempts	Will be assessed for the duration of study, an average of 16 weeks
Secondary	Cannabis Abstinence: continuous weeks of abstinence achieved during the 12 week treatment period	Urinalysis tests and self-report data will be collected twice per week during participation in the study	Will be assessed twice per week for the duration of the study treatment period, 12 weeks